Atlas Trials

Pharmacogenetics-guided Isoniazid Dosing in TB-HIV

Clinical trial NCT05124678 · UNKNOWN

Trial details

NCT number
NCT05124678
Sponsor
Makerere University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2021-12-07
Primary completion
2022-03-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.